TP53 and liver cancer: It has been shown to enhance reprogramming efficiency [67] and has been linked to the aggressiveness of esophageal cancer [68], the initiation and maintenance of liver cancer [69], chemoresistance in breast cancer [70], and the suppression of the p53 tumor suppressor gene [71].